Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized synthetic consensus immunogenic compositions targeting chondroitin sulfate proteoglycan 4 (CSPG4)

Optimized synthetic consensus immunogenic compositions targeting chondroitin sulfate proteoglycan 4 (CSPG4)

US Patent 12194000 · Granted Jan 14, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DNA antibody constructs for use against Pseudomonas aeruginosa2025
DNA monoclonal antibodies targeting PD-1 for the treatment and prevention of can2025
Vaccines against Zika virus2025
Canine distemper vaccines and methods of treatment using the same2025
Vaccines against Nipah virus, and methods of using same2025
DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)2025
Vaccines having an antigen and interleukin-21 as an adjuvant2025
Marburgvirus consensus antigens, nucleic acid constructs and vaccines made there2025
Filovirus consensus antigens, nucleic acid constructs and vaccines made therefro2025
Mayaro virus consensus antigens, DNA antibody constructs for use against Mayaro 2025
DNA monoclonal antibodies targeting CTLA-4 for the treatment and prevention of c2025
DNA-encoded monoclonal antibodies targeting the Ebolavirus glycoprotein2024